Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 15, 2017Anesthesiology

Abuse-deterrent Opioid Formulations

View Full Paper
Ask AI
Bookmark
Share

Authors

RLRonald S. LitmanRutgers, The State University of New JerseyOPOlivia H. PagánTCTheodore J. CiceroWashington University in St. Louis

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Litman et al. (2017) studied this question.

synapsesocial.com/papers/6a84305f31983d826d0ba575https://doi.org/10.1097/aln.0000000000002031
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Sustained reduction of diversion and abuse after introduction of an abuse deterrent formulation of extended release oxycodone2016 · 55 citations
  2. 2A Profile of OxyContin Addiction2004 · 126 citations
  3. 3Measuring online endorsement of prescription opioids abuse: an integrative methodology2012 · 35 citations
  4. 4A mechanistic investigation of thrombotic microangiopathy associated with IV abuse of Opana ER2016 · 40 citations
  5. 5Long-term opioid management for chronic noncancer pain2010 · 739 citations